CD274 and neoplasm: A similar approach was employed in the context of TNBC, wherein molybdenum disulfide (MoS2) was utilized as a delivery vehicle for anti-PDL1 antibody (aPDL1) and V9302, to potentiate the anti-tumor immune response in TNBC cells and markedly impede TNBC tumor growth.